Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease

Kidney International

Volumn 67, Issue 6, 2005, Pages 2393-2398

  Ib́añez, Luisa ^a   Morlans, Màrius ^b   Vidal, Xavier ^b   Martínez, María José ^b   Laporte, Joan Ramon ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Analgesics; Anti inflammatory agents; Case control studies; End stage renal disease; Nonsteroidal

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; AMINOPHENAZONE; ANALGESIC AGENT; DICLOFENAC; DIPYRONE; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; PARACETAMOL; PHENAZONE; PHENYLBUTAZONE; PIROXICAM; PROPYPHENAZONE; PYRAZOLONE DERIVATIVE; TENOXICAM;

ADULT; AGED; ANALGESIC NEPHROPATHY; ARTICLE; CASE CONTROL STUDY; CHRONICITY; CONTROLLED STUDY; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG HYPERSENSITIVITY; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INJURY; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PAIN; PRIORITY JOURNAL; RISK FACTOR; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; MIDDLE AGED; RISK;

ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO;

EID: 23044501420     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00346.x     Document Type: Article

References (22)

1. PRESCOTT LF: Analgesic nephropathy: A reassessment of the role of phenacetin and other analgesics. Drugs 23:75-149,1982
2. BREZIS M, ROSEN S: Hypoxia of the renal medulla-Its implications for disease. N Engl J Med 332:647-655,1995
3. DUBACH UC, ROSNER B, STÜRMER T: An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular mortality (1968 to 1987). N Engl J Med 324:155-160,1991
4. ELSEVIERS MM, DE BROE ME: A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 48:1912-1919,1995
5. REXRODE KM, BURING JE, GLYNN RJ, et al. Analgesic use and renal function in men. MMA 286:315-321, 2001
6. KURTH T, GLYNN RJ, WALKER AM, et al. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis 42:234-244, 2003
7. CURHAM GC, KNIGHT EL, ROSNER B, et al. Lifetime non-narcotic analgesic use and decline in renal function in women. Arch Intern Med 164:1519-1524, 2004
8. MURRAY TG, STOLLEY PD, ANTHONY JC, et al. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med 143:1687-1693,1983
9. POMMER W, BRONDER E, GREISER E, et al: Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 9:403-4l2, 1989
10. SANDLER DP, SMITH JC, WEINBERG CR, et al: Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243,1989
11. SANDLER DP, BURR FR, WEINBERG CR: Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 115:165-172,1991
12. MORLANS M, LAPORTE JR, VIDAL X, et al: End-stage renal disease and non-narcotic analgesics: A case-control study. Br J Clin Pharmacol 30:717-723,1990
13. PERNEGER TV, WHELTON PK, KLAG MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 331:1675-1679, 1994
14. FORED M, EJERBLAD E, LINDBLAD P, et al: Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 345:1801-1808, 2001
15. GRIFFIN MR, YARED A, RAY WA: Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 151:488-496, 2000
16. BENNETT WM, DE BROE ME: Analgesic nephropathy-A preventable renal disease. N Engl J Med 320:1269-1271,1989
17. ANONYMOUS: ATC Classification and DDD Assignment, Oslo, WHO Collaborating Centre for Drugs Statistics Methodology, 1996
18. DELZELL E, SHAPIRO S: A review of epidemiologic studies of non-narcotic analgesics and chronic renal disease. Medicine 77:102-121, 1998
19. PERSANTINE-ASPIRIN REINFARCTION STUDY RESEARCH GROUP: Persantine and aspirin in coronary heart disease. Circulation 62:449-461, 1980
20. KLIMT CR, KNATTERUD GL, STAMLER J, MEIER P: Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin. JACC 7:251-269,1986
21. WHELTON PK, RANDALL B, NEATON J, et al: Cigarette smoking and ESRD incidence in men screened for the MRFIT. J Am Soc Nephrol 6:408,1995
22. RUGGENENTI P, SCHIEPATTI A, REMUZZI G: Progression, remission, regression of chronic renal disease. Lancet 357:1601-1608, 2001